default author photo

Kangdong Liu

China-US (Henan) Hormel Cancer Institute

China

SCHOLARLY PAPERS

5

DOWNLOADS

404

TOTAL CITATIONS

3

Scholarly Papers (5)

1.

Aurora B Kinase as a Novel Molecular Approach for Osteosarcoma Therapy

Number of pages: 37 Posted: 11 Oct 2018
University of Minnesota - Austin - The Hormel Institute, University of Minnesota - Austin - The Hormel Institute, University of Minnesota - Austin - The Hormel Institute, China-US (Henan) Hormel Cancer Institute, China-US (Henan) Hormel Cancer Institute, University of Minnesota - Austin - The Hormel Institute, China-US (Henan) Hormel Cancer Institute, China-US (Henan) Hormel Cancer Institute, University of Minnesota - Austin - The Hormel Institute, University of Minnesota - Austin - The Hormel Institute, Henan Luoyang Orthopedic Hospital and University of Minnesota - Austin - The Hormel Institute
Downloads 126 (572,948)

Abstract:

Loading...

Targeted Therapy, Aurora Kinases, Mitosis, Osteosarcoma, HOI-07

2.

Mefloquine Inhibited Esophageal Squamous Cells Carcinoma Proliferation by Induction of Mitochondrial Autophagy

Number of pages: 41 Posted: 02 Aug 2019
Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology, University of Minnesota - Austin - The Hormel Institute and China-US (Henan) Hormel Cancer Institute
Downloads 96 (709,832)

Abstract:

Loading...

Esophageal squamous cell carcinoma (ESCC); Mefloquine (MQ); Mitochondrial autophagy

3.

Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma for Precision Oncology Research

Number of pages: 19 Posted: 28 Apr 2020
China-US (Henan) Hormel Cancer Institute, China-US (Henan) Hormel Cancer Institute, China-US (Henan) Hormel Cancer Institute, China-US (Henan) Hormel Cancer Institute, China-US (Henan) Hormel Cancer Institute, University of Minnesota - Austin - The Hormel Institute, China-US (Henan) Hormel Cancer Institute, China-US (Henan) Hormel Cancer Institute, China-US (Henan) Hormel Cancer Institute and University of Minnesota - Austin - The Hormel Institute
Downloads 74 (844,901)

Abstract:

Loading...

Esophageal Squamous Cell Carcinoma; Cancer Cell Line Encyclopedia; The Cancer Genome Atlas; Patient-Derived Xenograf

4.

Targeting the STAT5A/IDO1 Axis Overcomes Radiotherapy Resistance and Reverses Immunosuppressive Tumor Microenvironment in Non-Small Cell Lung Cancer

Number of pages: 51 Posted: 05 Jan 2022
Zhengzhou University - Department of Radiation Oncology, Zhengzhou University - Department of Radiation Oncology, Zhengzhou University - Department of Radiation Oncology, Zhengzhou University - Department of Radiation Oncology, Zhengzhou University - Department of Radiation Oncology, Zhengzhou University - Department of Radiation Oncology, Zhengzhou University - Department of Radiation Oncology, Zhengzhou University - Department of Radiation Oncology, China-US (Henan) Hormel Cancer Institute, China-US (Henan) Hormel Cancer Institute and Zhengzhou University - Department of Radiation Oncology
Downloads 63 (933,592)
Citation 2

Abstract:

Loading...

5.

Targeting EPRS is an Effective Therapeutic Strategy for Gastric Cancer

Number of pages: 73 Posted: 27 Oct 2020
Zhengzhou University - Department of Pathophysiology, China-US (Henan) Hormel Cancer Institute, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Oncology, China-US (Henan) Hormel Cancer Institute, China-US (Henan) Hormel Cancer Institute and China-US (Henan) Hormel Cancer Institute
Downloads 45 (1,121,190)
Citation 1

Abstract:

Loading...

EPRS, SCYL2, WNT/GSK-3β/β-catenin, XA, 4-HD, gastric cancer